Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, September 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

4 Biotech Stocks to Buy That May See Huge Volatility From Earnings

With the third-quarter earnings reporting season upon us, investors are checking their holdings and research to see just how things are shaping up for stocks they own. One thing is ...
Read Full Story »

Major Biotech, Pharma and FDA Catalysts Coming in October

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, August 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

Stocks were indicated to open lower on Monday, but investors know that the major stock indexes remain close to all-time highs. The primary trend that has prevailed for five or ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs Send Short Sellers Running for Cover

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. While nowhere near the ...
Read Full Story »

Short Sellers Run for Cover From Major Biotech Stocks

The short interest data are out for the most recent settlement date, July 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, June 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotech Short Interest Surges

The short interest data are out for the most recent settlement date, June 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Large Insider Buying at Alexion Raises Investors’ Eyebrows

Most of the large biotech outfits in America have gone into a limbo mode. Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) fits that bill despite having a $26.5 billion market cap. Is ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

June 14, 2017: The S&P 500 closed lower, down 0.1% at 2,437.90. The DJIA closed up 0.2% at 21,376.47. Separately, the Nasdaq closed lower 0.4% at 6,194.89. Wednesday saw a mixed ...
Read Full Story »

Alexion Pharmaceuticals Adds New CFO From Biogen

Shares of Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) saw a handy gain early on Wednesday after the company announced that there would be changes in its leadership. The company announced that ...
Read Full Story »